相关实验视频

Updated: Jun 18, 2025

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

在转移性冠状腺黑色素瘤的情况下延长存活时间,并接受免疫治疗

Ibadulla Mirzayev^1,2, Ahmet Kaan Gündüz^1,3, Leyla Mirzayeva⁴

¹Department of Ophthalmology, Ankara University Faculty of Medicine.

Anti-cancer drugs

|July 30, 2024

概括

这项研究报告了一名患有转移性脑膜黑色素瘤的患者成功存活了三年,该患者接受了尼沃卢马布,伊皮利穆马布和跨动脉放射栓塞治疗. 这些免疫检查点抑制剂为晚期眼部癌症提供了新的希望.

科学领域:

眼科医生眼科眼科
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

卵巢黑色素瘤是成年人中最常见的初级眼内癌症.
转移性疾病显著降低了生存率,在晚期病例中,5年生存率低于1%.
免疫检查点抑制剂 (ICI) 在治疗转移性癌症方面表现有前途.

研究的目的:

呈现一种晚期毛细膜黑色素瘤病例,肝脏转移.
评估ICI和跨动脉放射栓塞联合治疗的疗效.
在具有挑战性的临床场景中报告长期生存结果.

主要方法:

治疗包括尼沃卢马布 (抗PD-1) 和伊皮利穆马布 (抗CTLA-4) 免疫检查点抑制剂.
跨动脉放射栓塞用于肝转移管理.
在三年内监测临床反应和生存期.

主要成果:

患者实现了三年生存期.
组合疗法在治疗转移性脑膜黑色素瘤方面显示出积极的反应.
这一案例凸显了多式联络治疗策略的潜力.

结论:

与尼沃卢马布和伊皮利穆马布的联合免疫疗法,以及跨动脉放射栓塞,可以导致转移性阴膜黑色素瘤的长期存活.
这种方法为那些治疗选择有限的患者提供了可行的选择.
需要进一步研究膜黑色素瘤的组合疗法.

更多相关视频

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.